Skip to content

The UK Patent Box needs a patent. Most software companies do not have one.

The UK Patent Box taxes qualifying profit at an effective 10%, but the relief attaches to granted patents. Most software companies protect their work by copyright and have never filed one, so they read about the regime and then discover it was not built for them. The Cyprus IP Box covers copyrighted software and taxes qualifying profit at approximately 3%.


A founder reads that the UK taxes intellectual property profit at 10% rather than 25%, does the arithmetic on their own numbers, and books a call with their accountant. Then they find out what the relief actually attaches to, and the conversation ends in about four minutes.

This is the most common dead end in UK technology tax, and it is worth understanding properly, because the reason it fails tells you exactly what to look at instead.

What the UK Patent Box is

The Patent Box was introduced by the Finance Act 2012 and took effect from 1 April 2013. It applies a reduced effective rate of corporation tax, 10%, to profits attributable to qualifying intellectual property, against a main rate that has been 25% since the 2023 to 2024 financial year.

Mechanically it is not a separate rate. HMRC delivers the relief as an additional deduction, calculated so that the benefit to the company is equivalent to taxing the relevant IP profits at 10%. The distinction matters when you model it, because the deduction interacts with the rest of your computation rather than sitting beside it.

It is also not automatic. A company has to elect in, and the election must be made within two years after the end of the accounting period in which the relevant profits arose. Miss the window and the relief for that period is gone.

The condition that decides it

To benefit, your company must own or exclusively licence in patents granted by specified bodies, and your company or another group company must have undertaken qualifying development on the patent. Certain other rights qualify too, notably some medicinal and botanic innovation rights, which is why the regime has always been more useful to pharmaceutical and engineering businesses than to anyone else.

Read that again with a software business in mind. The relief attaches to a granted patent. Not to intellectual property in general, not to proprietary technology, not to code you wrote and own.

Why most software companies fall outside it

Software is protected by copyright automatically, from the moment it is written. That protection is free, immediate and requires no application to anybody.

Patents are the opposite. They cost money, they take years, they require the invention to be novel and non-obvious, and in Europe software as such is excluded from patentability unless it makes a technical contribution beyond the running of the program itself. Plenty of software is patentable in principle. Very little of it is patented in practice, because for most SaaS businesses the commercial advantage is shipping speed and distribution rather than a defensible invention, and a patent that publishes your method to competitors while taking three years to grant is a poor trade.

So the ordinary position for a profitable UK software company is: substantial profit clearly attributable to technology the company built, and no granted patent anywhere in the group. The Patent Box has nothing to attach to.

The regime's own statistics tell the same story. HMRC publishes Patent Box relief figures annually, and the claimant population has always been concentrated in a small number of large companies in manufacturing and pharmaceuticals rather than spread across the technology sector.

What to do if you do hold patents

If your company does hold granted patents, or could realistically obtain them, the Patent Box deserves proper attention rather than a paragraph in an article. Three things are worth knowing before you start.

Qualifying development is a real test. Holding the patent is not enough. The company, or another company in the group, must have made a significant contribution to creating or developing the invention, or to a product incorporating it.

Streaming and the nexus rules changed the calculation. The Patent Box was revised to comply with international rules on preferential IP regimes, which require the benefit to track the R&D the claimant actually did. Claims now work on a streamed basis, tracking income and expenditure per IP asset or product family. The practical consequence is record-keeping: you need R&D expenditure attributable to each stream, and you need it from the start rather than reconstructed later.

Elect early even if the benefit is small. The two-year window is unforgiving, and an election costs nothing if the numbers turn out not to help.

The same asset, treated differently

Now the part that matters if you have no patents.

The UK is not the only country that operates a preferential regime for intellectual property. They exist across the EU, and since the OECD's work on harmful tax practices they all share a common framework: the benefit has to track the research and development the claimant genuinely performed. That is the modified nexus approach, and it is why these regimes survived an international clampdown that closed a great many others.

What differs between them is the definition of a qualifying asset. The UK chose patents. Cyprus chose a wider definition that includes copyrighted software.

That single drafting decision is the whole of the difference for a SaaS business. The asset is identical. Your platform is the same platform. One jurisdiction says it does not qualify because you never filed a patent on it, and another says it qualifies because copyright is how software is protected.

How the Cyprus IP Box works

The mechanism is a deduction rather than a rate. Eighty per cent of qualifying profit from qualifying intellectual property is deducted, and the remaining twenty per cent is taxed at the Cyprus corporate rate of 15%. That produces an effective rate of approximately 3% on the qualifying share.

The corporate rate of 15% comes from the 2026 reform, Law 207(I)/2025, gazetted on 31 December 2025 and in force for accounting periods beginning on or after 1 January 2026. The IP Box itself sits in Article 9(1)(l) of the Income Tax Law and the reform left it unchanged.

Set the two regimes side by side and the shape is clear. The UK gives you 10% if you have a granted patent. Cyprus gives you approximately 3% if you have copyrighted software and the development behind it stands up.

The conditions, because approximately 3% is a floor

A comparison that stopped there would be doing exactly what this article criticises. Approximately 3% is the floor the regime produces when the qualifying share is at or near its maximum. Four things decide whether you get near it.

The asset has to be the right kind. Copyrighted software qualifies: platform code, engines, trading bridges, algorithms, models, proprietary tooling. Brands, trademarks and other marketing intangibles are excluded, permanently and by design.

The income has to trace to it. Qualifying income includes licence and royalty income and qualifying income embedded in the products and services you sell. That embedded limb is what makes the regime workable for subscription software, where nobody is paying a separately invoiced licence fee.

Nexus decides how much qualifies. The share of profit that gets the reduced rate tracks qualifying R&D expenditure against total expenditure on the asset. Development the Cyprus company funds itself, or outsources to unrelated third parties, counts. Acquisition cost of buying in existing IP does not, and development recharged from group companies outside Cyprus does not. A smaller qualifying share moves the effective rate up, never down.

The company has to be real. It must genuinely develop and control the asset: a resident technical lead and core engineering team approving releases locally, board control on the island, intra-group pricing set at arm's length and documented. Ownership on paper is not enough, and it is also the point at which most people discover this is an operating decision rather than a tax one.

The comparison nobody runs

Here is the honest framing. For a UK company with granted patents, the Patent Box is simpler, domestic, and requires no operational change: you elect, you stream your income, you claim. Ten per cent on qualifying profit with no relocation is a good outcome and you should take it.

For a UK company without patents, the Patent Box is not a slower option or a harder option. It is not an option. And the choice is not between 10% and 3%, it is between 25% and whatever a properly built structure produces on your facts, against the cost of building genuine substance somewhere else.

That is an arithmetic question with a real answer, and the answer is different for a company making £400,000 of software profit than for one making £4m. Below some level the cost of doing it properly exceeds the benefit, and anyone who tells you otherwise is selling.

What a serious answer requires

Two documents, in this order.

A view on whether your income and your development history actually produce a qualifying share worth having. That is the nexus calculation, and it depends on facts you already have: who funded the development, where it happened, whether anything was bought in.

Then a formal opinion from a regulated Cyprus tax advisor, before anything moves. Not from us. We design and run the structure the opinion describes; we do not write it and we do not sign it, and any firm that offers to do both is telling you something about how the position will hold up when it is tested.

If you hold patents, talk to your UK advisers about electing into the Patent Box, and do it inside the two-year window. If you do not, the question is whether the asset your company built is sitting in the right place, and that is worth an hour of somebody's time to establish either way.

Sources

Talk to us

Whether any of this applies to your facts is a different question from whether it is true. One call answers it.

Book the 45 minutes